Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial.

MLA

Locatelli, F., et al. “Cyclosporin A and Short-Term Methotrexate versus Cyclosporin A as Graft versus Host Disease Prophylaxis in Patients with Severe Aplastic Anemia given Allogeneic Bone Marrow Transplantation from an HLA-Identical Sibling: Results of a GITMO/EBMT Randomized Trial.” Blood, vol. 96, no. 5, Sept. 2000, pp. 1690–97. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10961865&authtype=sso&custid=ns315887.

APA

Locatelli, F., Bruno, B., Zecca, M., Van-Lint, M. T., McCann, S., Arcese, W., Dallorso, S., Di Bartolomeo, P., Fagioli, F., Locasciulli, A., Lawler, M., & Bacigalupo, A. (2000). Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood, 96(5), 1690–1697.

Chicago

Locatelli, F, B Bruno, M Zecca, M T Van-Lint, S McCann, W Arcese, S Dallorso, et al. 2000. “Cyclosporin A and Short-Term Methotrexate versus Cyclosporin A as Graft versus Host Disease Prophylaxis in Patients with Severe Aplastic Anemia given Allogeneic Bone Marrow Transplantation from an HLA-Identical Sibling: Results of a GITMO/EBMT Randomized Trial.” Blood 96 (5): 1690–97. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10961865&authtype=sso&custid=ns315887.